Compare Anlon Healthcare with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
INR 577 Cr (Micro Cap)
29.00
32
0.00%
0.07
9.57%
2.71
Total Returns (Price + Dividend) 
Anlon Healthcare for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Closure of Trading Window
02-Mar-2026 | Source : BSEWe have attached notice of closure of Trading Window for dealing in securities of the Company as per SEBI (PIT) Regulation Kindly take the same on your record. Thank you.
Board Meeting Intimation for Stock Split And Issue Of Bonus Shares
02-Mar-2026 | Source : BSEAnlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/03/2026 inter alia to consider and approve 1. To consider and approve subject to shareholders approval the subdivision (stock split) of existing equity shares of the Company and to fix the Record Date for the same if approved. 2. To consider and recommend to increase in Authorized Share Capital and consequential Alteration in Capital Clause of the Memorandum of Association of the Company. 3. To consider and approve subject to shareholders approval the issue of Bonus Equity Shares to the equity shareholders of the Company on such terms and in such proportion as may be determined by the Board of Directors. 4. Any other business(s) with permission of the Chair if any. You are requested to take the above information on your record. Thanking You.
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
27-Feb-2026 | Source : BSEWe have attached herewith announcement regarding amendment in Share Purchase Agreement executed between Anlon Healthcare Limited and Bizotic Lifescience Private Limited. Kindly take the same on your record. Thank you.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 4 FIIs (0.23%)
Punitkumar R Rasadia (34.98%)
Shree Dwarikadhish Ventures Llp (7.53%)
23.58%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Nine Monthly Results Snapshot (Standalone) - Dec'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






